Longevity extension of worker honey bees (Apis mellifera) by royal jelly: optimal dose and active ingredient

av Yang, Wenchao, Tian, Yuanyuan, Han, Mingfeng, Miao, Xiaoqing
I publikationen PeerJ (2017)

Anti-hypertensive and cardioprotective effects of a novel apitherapy formulation via upregulation of peroxisome proliferator-activated receptor-α and -γ in spontaneous hypertensive...

av Sun, Yanru, Han, Mingfeng, Shen, Zhenhuang, Huang, Haibo, Miao, Xiaoqing
I publikationen Saudi J Biol Sci (2018)

A Study on the Predictors of Disease Severity of COVID-19

av Li, Liang, Sun, Wei, Han, Mingfeng, Ying, Yunli, Wang, Quanzhi
I publikationen Med Sci Monit (2020)

Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19

av Zha, Lei, Shen, Ya, Pan, Lingling, Han, Mingfeng, Yang, Gang, Teng, Xiaobao, Tefsen, Boris
I publikationen J Infect (2021)

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67

av Cui, Minhu, Jin, Mingji, Han, Mingfeng, Zang, Yingda, Li, Chuangjun, Zhang, Dongming, Huang, Wei, Gao, Zhonggao, Yin, Xuezhe
I publikationen Int J Nanomedicine (2020)

Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19

av Gao, Yong, Li, Tuantuan, Han, Mingfeng, Li, Xiuyong, Wu, Dong, Xu, Yuanhong, Zhu, Yulin, Liu, Yan, Wang, Xiaowu, Wang, Linding
I publikationen J Med Virol (2020)

COVID-19 induced liver function abnormality associates with age

av Li, Shasha, Li, Jinsong, Zhang, Zhenhua, Tan, Lin, Shao, Tuo, Li, Ming, Li, Xiuyong, Holmes, Jacinta A., Lin, Wenyu, Han, Mingfeng
I publikationen Aging (Albany NY) (2020)

Improving anti-tumor outcomes for colorectal cancer therapy through in situ thermosensitive gel loading harmine

av Li, Zhenzhen, Chen, Liqing, He, Chenghui, Han, Ying, Han, Mingfeng, Zhang, Yingying, Qi, Lingling, Xing, Xuezhong, Huang, Wei, Gao, Zhonggao, Xing, Jianguo
I publikationen Am J Transl Res (2020)

Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China

av Wang, Ruirui, Pan, Min, Zhang, Xiumei, Han, Mingfeng, Fan, Xiaoyun, Zhao, Fengde, Miao, Manli, Xu, Jing, Guan, Minglong, Deng, Xia, Chen, Xu, Shen, Leilei
I publikationen Int J Infect Dis (2020)

Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study

av Zheng, Xueying, Luo, Sihui, Sun, Yong, Han, Mingfeng, Liu, Jian, Sun, Liangye, Zhang, Liangming, Ling, Ping, Ding, Yu, Jin, Tengchuan, Liu, Zhirong, Weng, Jianping
I publikationen Natl Sci Rev (2020)

Effective treatment of severe COVID-19 patients with tocilizumab

av Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
I publikationen Proc Natl Acad Sci U S A (2020)

Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference

av Zhang, Yafei, Wang, Changtai, Han, Mingfeng, Ye, Jun, Gao, Yong, Liu, Zhongping, He, Tengfei, Li, Tuantuan, Xu, Mengyuan, Zhou, Luping, Zou, Guizhou, Lu, Mengji, Zhang, Zhenhua
I publikationen Virol Sin (2020)

Correction to: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference

av Zhang, Yafei, Wang, Changtai, Han, Mingfeng, Ye, Jun, Gao, Yong, Liu, Zhongping, He, Tengfei, Li, Tuantuan, Xu, Mengyuan, Zhou, Luping, Zou, Guizhou, Lu, Mengji, Zhang, Zhenhua
I publikationen Virol Sin (2020)

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

av Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
I publikationen Proc Natl Acad Sci U S A (2020)

Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients

av Xu, Xiaoling, Han, Mingfeng, Li, Tiantian, Sun, Wei, Wang, Dongsheng, Fu, Binqing, Zhou, Yonggang, Zheng, Xiaohu, Yang, Yun, Li, Xiuyong, Zhang, Xiaohua, Pan, Aijun, Wei, Haiming
I publikationen Proc Natl Acad Sci U S A (2020)

Differentially expressed immune response genes in COVID-19 patients based on disease severity

av Li, Shasha, Duan, Xiaoqiong, Li, Yujia, Li, Ming, Gao, Yong, Li, Tuantuan, Li, Shilin, Tan, Lin, Shao, Tuo, Jeyarajan, Andre J., Chen, Limin, Han, Mingfeng, Lin, Wenyu, Li, Xiuyong
I publikationen Aging (Albany NY) (2021)

Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial

av Hu, Ke, Guan, Wei-jie, Bi, Ying, Zhang, Wei, Li, Lanjuan, Zhang, Boli, Liu, Qingquan, Song, Yuanlin, Li, Xingwang, Duan, Zhongping, Zheng, Qingshan, Yang, Zifeng, Liang, Jingyi, Han, Mingfeng, Ruan, Lianguo, Wu, Chaomin, Zhang, Yunting, Jia, Zhen-hua, Zhong, Nan-shan
I publikationen Phytomedicine (2021)

Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity

av Han, Mingfeng, Xu, Mengyuan, Zhang, Yafei, Liu, Zhongping, Li, Shasha, He, Tengfei, Li, Jinsong, Gao, Yong, Liu, Wanjun, Li, Tuantuan, Chen, Zixiang, Huang, Xin, Cheng, Guoling, Wang, Jun, Dittmer, Ulf, Witzke, Oliver, Zou, Guizhou, Li, Xiuyong, Lu, Mengji, Zhang, Zhenhua
I publikationen Med Microbiol Immunol (2020)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

av Tang, Wei, Cao, Zhujun, Han, Mingfeng, Wang, Zhengyan, Chen, Junwen, Sun, Wenjin, Wu, Yaojie, Xiao, Wei, Liu, Shengyong, Chen, Erzhen, Chen, Wei, Wang, Xiongbiao, Yang, Jiuyong, Lin, Jun, Zhao, Qingxia, Yan, Youqin, Xie, Zhibin, Li, Dan, Yang, Yaofeng, Liu, Leshan, Qu, Jieming, Ning, Guang, Shi, Guochao, Xie, Qing
I publikationen BMJ (2020)

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

av Wang, Dongsheng, Fu, Binqing, Peng, Zhen, Yang, Dongliang, Han, Mingfeng, Li, Min, Yang, Yun, Yang, Tianjun, Sun, Liangye, Li, Wei, Shi, Wei, Yao, Xin, Ma, Yan, Xu, Fei, Wang, Xiaojing, Chen, Jun, Xia, Daqing, Sun, Yubei, Dong, Lin, Wang, Jumei, Zhu, Xiaoyu, Zhang, Min, Zhou, Yonggang, Pan, Aijun, Hu, Xiaowen, Mei, Xiaodong, Wei, Haiming, Xu, Xiaoling
I publikationen Front Med (2021)